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Background: Clonorchis sinensis (C. sinensis, Cs) is a trematode parasite that often causes chronic cumulative
infections in the hepatobiliary ducts of the host and can lead to pathological changes by continuously released
excretory/secretory proteins (ESPs). A T2 ribonuclease in trematode ESPs, has been identified as a potent regulator
of dendritic cell (DCs) modulation. We wondered whether there was a counterpart present in CsESPs with similar
activity. To gain a better understanding of CsESPs associated immune responses, we identified and characterized
RNASET2 of C. sinensis (CsRNASET2) in this paper.
Methods: We expressed CsRNASET2 in Pichia pastoris and identified its molecular characteristics using bioinformatic
analysis and experimental approaches. The immune modulation activities of CsRNASET2 were confirmed by
evaluating cytokine production and surface markers of recombinant CsRNASET2 (rCsRNASET2) co-cultured DCs, and
monitoring levels of IgG isotypes from rCsRNASET2 administered BALB/c mice.
Results: CsRNASET2 appeared to be a glycoprotein of T2 ribonuclease family harboring conserved CAS motifs and rich
in B-cell epitopes. Furthermore, CsRNASET2 was present in CsESPs and was able to modulate cytokine production of
DCs. In addition, rCsRNASET2 could significantly suppress the expression of lipopolysaccharide-induced DCs maturation
markers. In addition, when subcutaneously administered with rCsRNASET2 there was a marked effect on IgG isotypes in
mouse sera.
Conclusion: Collectively, we revealed that CsRNASET2, a T2 ribonuclease present in CsESPs, could modulate DCs
maturation and might play an important role in C. sinensis associated immune regulation in the host.
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Immune modulationBackground
Clonorchiasis, caused by the infection of Clonorchis
sinensis (C. sinensis), is highly epidemic in several Asian
countries. More than 35 million people are infected with
C. sinensis globally [1]. Clonorchiasis is predominantly
caused by ingesting raw or undercooked freshwater fish
harboring metacercariae [2]. When ingested by the host,
larvae excyst in the duodenum and then migrate into* Correspondence: huang66@mail.sysu.edu.cn; yuhxteam@163.com
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stated.the peripheral intrahepatic bile ducts to develop as adult
worms [3]. C. sinensis adult worms can thrive for more
than 10 years in humans [4]. People infected with C.
sinensis are often asymptomatic, however, repeated and
chronic infections can eventually lead to various hepato-
biliary symptoms and complications. During the long
term of parasitism, the liver flukes continuously release
excretory/secretory proteins (ESPs), a cocktail of hun-
dreds to thousands of bioactive proteins. Prior studies
have demonstrated that the components of ESPs from
C. sinensis (CsESPs) are implicated in biological pro-
cesses especially the induction of host immune response
[5], which may be intimately associated with formationThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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[6]. Owing to its carcinogenicity, C. sinensis has been re-
garded as a group I carcinogen of cholangiocarcinoma [7].
T2 ribonucleases are transferase-type RNase and distri-
bute broadly in almost all groups of living organisms in-
cluding bacteria, fungi, virus, plants, and animals [8]. All
of these enzymes have diverse biological activities, such as
degradation of self-RNA, clearance of nucleic acids, ser-
ving as extra- or intracellular cytotoxins, and regulation of
host immune responses [8-10]. Numerous studies have
been conducted to characterize the biochemical properties
and immunoregulatory roles of a T2 ribonuclease (omega-
1) in Schistosoma mansoni (Smomega-1), which is present
in soluble egg antigens (SEA) of S. mansoni, formed by
egg released ESPs [11-13]. Smomega-1 could trigger Th2
response by modulating dendritic cells (DCs) phenotype,
structure and protein synthesis [14-16]. Moreover, Smo-
mega-1 has been reported to induce priming of Foxp3+
Tregs, which play crucial immunoregulatory roles in the
process of S. mansoni infection [17]. Interestingly, the
function of Smomega-1 to enhance Foxp3 expression also
depends on the alteration of DCs. These findings illustrate
that Smomega-1 is a key component of ESPs to modulate
host immune responses, which is elicited by DCs alter-
ation. DCs are defined as professional antigen-presenting
cells serving as the sentinels of the immune system and
have the unique capacity to induce and coordinate both
innate and adaptive immune responses [18-22]. These
findings give us insight into interactions between a se-
creted antigen and DCs, leading us to gain a better under-
standing of helminth associated immune responses.
In the present study, we expressed and characterized C.
sinensis RNASET2 (CsRNASET2). We investigated the ef-
fects of rCsRNASET2 on bone marrow derived dendritic
cell (BMDCs) modulation. In addition, we evaluated
humoral immune responses initiated by rCsRNASET2 in
BALB/c mice. Based on these observations, we proposed
that CsRNASET2 was intimately associated with C. sinen-
sis-triggered immune response in the host.
Methods
Animals
Female 6- to 8-week-old BALB/c mice and SD rats were
obtained from the animal center of Sun Yat-Sen Univer-
sity (Guangzhou, China). The animals were housed in a
pathogen-free facility. All animal experiments were con-
ducted under Animal Care and Use Committee of Sun
Yat-sen University (Permit No: SCXK (Guangdong)
2009–0011).
Sequence analysis of CsRNASET2
The full-length encoding sequence of CsRNASET2 [Acces-
sion No. GAA50115.1] was downloaded from GenBank in
NCBI [http://www.ncbi.nlm.nih.gov/]. Homology analysiswas performed using the blastx program [http://blast.ncbi.
nlm.nih.gov/]. The molecular characteristics and the func-
tional domains of CsRNASET2 were assessed using proteo-
mics tools provided by Expasy website [http://www.expasy.
org/]. The alignments of the deduced amino acid sequence
and T2 amino acid sequences from other species were per-
formed by the software Vector NTI suite 8.0.
Preparation of antigens and polyclonal antibodies
Recombinant CsRNASET2 was expressed in P. pastoris ac-
cording to the manufacturer’s protocol (Invitrogen, USA).
RNase activity of rCsRNASET2 was identified, and deglyco-
sylation assay of the protein was carried out with PNGase F
(New England BioLabs, USA). We collected CsESPs
referring to the protocol as previously described [23].
Each BALB/c mouse was immunized subcutaneously
with 100 μg rCsRNASET2 or ESPs, which were respect-
ively emulsified with complete Freund’s adjuvant at the
first injection. Two booster injections at 2-week intervals
were performed with 50 μg of proteins, which were emul-
sified with incomplete Freund’s adjuvant. After 2 weeks of
the final boosting, anti-sera were collected and antibody
titers were determined by ELISA. All anti-sera samples
were split and stored at − 80°C.
Western blotting
rCsRNASET2 and CsESPs were subjected to 12% SDS-
PAGE, and subsequently electrotransferred onto the PVDF
membranes (Millipore, USA) for 1 h at 100 V. The mem-
branes were then blocked with 5% skimmed milk in PBS
for 2 h at room temperature, and incubated with myc-
epitope monoclonal antibody (1:1000 dilutions), his-tag
monoclonal antibody, mouse anti-rCsRNASET2 sera
(1:2000 dilutions), mouse anti- ESPs sera, naïve mouse
and C. sinensis-infected mouse sera (1:100 dilutions)
respectively. The membranes were then incubated with
peroxidase-conjugated goat anti-mouse IgG (Proteintech,
USA, 1:10,000 dilutions) for 1 h at room temprature. The
reactions were visualized by enhanced chemiluminescence
(ECL) method.
Generation and stimulation of bone marrow derived
dendritic cells
Femurs were obtained from BALB/c mice and the muscle
tissues were removed with scissors. The bone marrow
cells (BMCs) were isolated by flushing the bone marrow
with chilled RPMI-1640 medium. Red blood cells were
lysed with red blood cell lysing buffer (Sigma, USA). The
remaining BMCs were washed twice and then resus-
pended into 2 × 106/ml. BMCs were cultured in complete
RPMI-1640 supplemented with 20 ng/ml mouse GM-CSF
(R&D Systems, USA) and 10 ng/ml mouse IL-4 (R&D Sys-
tems). On days 3 and 5, fresh culture medium including
the supplements were added. Immature BMDCs were
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concentrations of rCsRNASET2 (0.05-50 μg/ml) or ESPs
(10–160 μg/ml) in the presence of 1 μg/ml LPS (sigma) for
12, 24 and 48 h. Generally, Th1- and Th2-polarizing Ag
stimulate DCs via discrete pathways, coupled with distinct
modifications of the DC maturation. Therefore, we utilized
rCsFABP, a protein has been reported to induce Th1 im-
mune responses, as a control protein [24,25].
Flow cytometry
Surface markers on pretreated BMDCs were detected
by FCM using the following mAbs: FITC labeled anti-
CD11c (eBioscience, USA), PE labeled anti-CD80, anti-
CD86, APC labeled anti-CD40 (BD PharMingen, USA). For
staining, BMDCs were washed twice with PBS containingFigure 1 Sequence alignment of RNASET2 from C. sinensis with homo
sequences are shaded in black. The conserved ribonuclease T2 CAS I and C
histidine residues in the CAS regions are indicated by black triangles. A N-l
epitopes are labeled by dots. GenBank Accession Numbers: C.s, Clonorchis s
Schistosoma mansoni, [ABB73003.1]; F.c, Felis catus, [XP_003986767.1]; H.s, H
norvegicus, [NP_001099680.1].0.1% BSA and 0.05% sodium azide. The cells were there-
after incubated with the respective mAbs for 30 min at 4°C
in the dark. Then, cells were washed twice and resuspended
in PBS. Flow cytometry was performed on a Beckman
Coulter Gallios cytometer and analyzed using the Kaluza
software (Beckman Coulter, USA).
ELISA
Cell-free supernatants were harvested at different time
points after stimulation, and levels of IL-12p70 and IL-
10 were assessed by commercially available ELISA kits
(eBioscience) according to the manufacturer’s protocol.
Sera were collected from rCsRNASET2 immunized mice
or PBS immunized mice at 4 and 6 weeks after primary in-
jection. Levels of IgG1 and IgG2a in sera were evaluatedlogues from other species. The identical amino acids of all aligned
AS II domains are marked with box1 and box2. Two highly conserved
inked glycosylation site is marked with box3 and an arrow. The B cell
inensis, [GAA50115.1]; S.j, Schistosoma japonicum, [AAW26577.1]; S.m,
omo sapiens, [AAH51912.1]; M.u, mus musculus, [AAI00331.1]; R.a, rattus
Figure 2 Determination of CsRNASET2 as a component of C.
Sinensis ESPs. (A) The deglycosylation assay of rCsRNASET2 was
evaluated by SDS-PAGE protein molecular weight markers (M);
untreated rCsRNASET2 (lane 1); CsESPs (lane 2); rCsRNASET2 incubated
with PNGase F deglycosylation enzyme (lane 3). (B) Western blotting
analysis of rCsRNASET2. The rCsRNASET2 reacted with sera from
mice infected with C. sinensis (lane 1); mice immunized with
rCsRNASET2 (lane 2), mice immunized with CsESPs (lane 3)
and naïve mouse (lane 4); CsESPs reacted with sera from mice
immunized with rCsRNASET2 (lane 5). One of four independent
experiments is shown.
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well overnight at 4°C. ELISA plates were blocked with 5%
skimmed milk for 2 h at 37°C and then incubated with
sera for 2 h at 37°C. Subsequently, the plates were incu-
bated with HRP-conjugated goat anti-mouse IgG1 and
IgG2a (invitrogen) for 1 h at 37°C. The optical density was
tested at 450 nm.
Statistical analysis
Data were routinely analyzed by the GraphPad Prism 5
software. The Mann–Whitney test was performed to cal-
culate statistical significance of differences between two
groups of observations. p -Values < 0.05 were considered
statistically significant.
Results
Sequence analysis of CsRNASET2
The complete coding sequence of CsRNASET2 con-
tained 690 bp encoding a putative protein of 229 amino
acids with the predicted molecular weight of 26.6 kDa.
The hypothetical pI of the deduced protein was 5.65.
The estimated half-life of CsRNASET2 was more than
20 hours in yeast and more than 10 hours in E. coli. The
instability index of the deduced protein was 35.40, indi-
cating CsRNASET2 might be a stable protein. Blastx
analysis showed that the sequence was a glycoprotein of
the T2 ribonuclease family, which contained two critical
histidine residues in the CAS motifs. However, the se-
quence just shared 43% and 39% identity with its homo-
logues from S. janpani and S. mansoni, and it was rich
in B-cell epitopes, which might suggest CsRNASET2 as
being a good immunogen (Figure 1).
Identification of CsRNASET2 as a component of
C. Sinensis ESPs
We successfully expressed rCsRNASET2 (Additional file
1: Figure S1A) and identified its c-myc epitope and
his-tag by western blot (Additional file 1: Figure S1B).
The RNase activity of rCsRNASET2 was determined
(Additional file 1: Figure S2). We noted that deglycosyl-
ated rCsRNASET2 displayed ~4 kDa reduction of mo-
lecular weight (Figure 2A). In addition, rCsRNASET2
could be probed by anti-CsRNASET2, anti-CsESPs and C.
sinensis-infected mouse sera at a prominent single band
around 35 kDa, whereas the protein could not be recog-
nized by sera from naïve mice. In addition, CsESPs reacted
with mouse anti-CsRNASET2 sera at a single band around
27 kDa (Figure 2B). These results indicated that rCsRNA-
SET2 was indeed a component of CsESPs with glycosyla-
tion and RNase activity.
Cytokine production of BMDCs in response to rCsRNASET2
IL-12p70 and IL-10 are potent adjustive cytokines in the
immune system, which can be secreted by DCs [26,27].We incubated BMDCs with LPS in the presence or ab-
sence of various concentrations of rCsRNASET2, ESP or
0.5 μg/ml rCsFABP. We found that both rCsRNASET2
and CsESPs suppressed the LPS-induced up-regulation of
IL-12p70 on BMDCs in a dose-dependent manner at the
indicated time points (Figure 3A). In contrast, CsESPs (20–
80 μg/ml) enhanced the expression of IL-10 in a dose-
dependent manner, and rCsRNASET2 could promote
IL-10 synthesis only at a concentration of 0.5 μg/ml
(Figure 3B). In addition, rCsFABP could not obviously
interfere with the cytokine production of DCs.
Effects of rCsRNASET2 on BMDCs phenotypic modifications
A previous study has demonstrated that helminth antigens
can affect the maturation of DCs [28]. To confirm the ef-
fects of CsRNASET2 on DCs maturation, BMDCs were
treated with LPS in the presence or absence of rCsRNA-
SET2, rCsFABP (control protein) or ESPs for 24 h, and a
series of surface markers expressed on DCs were assessed.
Figure 3 Cytokine production by BMDCs in response to rCsRNASET2. BMDCs (2 × 106/ml) were incubated with 1 μg/ml LPS in the presence
or absence of various concentrations of (10, 20, 40, 80 and 160 μg/ml) ESPs, (0.05, 0.5, 5 and 50 μg/ml) rCsRNASET2 or (0.5 μg/ml) rCsFABP.
Supernatants were harvested at different time points after stimulation and evaluated by ELISA for expression of IL-12p70 (A) and IL-10 (B). Error
bars represent mean cytokine concentrations ± SD (n = 5). Statistical significance was analyzed by the Mann–Whitney test (*p < 0.05, **p < 0.01, ns:
not significant).
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CD11c, CD40, CD80 and CD86 on BMDCs were raised,
when rCsRNASET2 or ESPs were added, the LPS-triggered
up-regulation of surface markers was strikingly reduced. In
contrast, rCsFABP had no significant effect on the expres-
sion of these surface markers (Figure 4A, B).
IgG isotype analysis of rCsRNASET2 immunized mice
For mice, the IgG1 response generally represents Th2-
activity, while IgG2a represents Th1-activity [29]. We
evaluated the levels of IgG1 and IgG2a in sera obtained
from rCsRNASET2 immunized mice. The data shown
in Figure 5 shows that administration of rCsRNASET2
triggered a markedly higher IgG1 expression than
IgG2a compared with control mice at week 4 (1.99 ±
0.12 versus 0.26 ± 0.04, p < 0.0001) and week 6 (2.88 ±
0.22 versus 0.49 ± 0.31, p = 0.0002).
Discussion
It is well demonstrated that DCs are dominant players
in the initiation and sustenance of immune responses
[19-22]. In general, DCs undergo activation, termedmaturation, upon recognition of invading pathogens,
such as viruses, bacteria, and fungi. In the process of
maturation, DCs up-regulate the production of surface
markers and polarizing cytokines [20,21]. However, re-
cent studies have indicated that DCs exposed to antigens
derived from parasitic helminths fail to induce the clas-
sical DC activation [30-32]. The maturation status of
DCs is crucial for the initiation of primary immune re-
sponses. It has been documented that Smomega-1, a
RNase T2 family glycoprotein present in ESP, is a major
molecule to dramatically modulate the maturation of
DCs in S. mansoni infections [14-17].
Since Smomega-1 has been reported to play a potent
role in the process of DCs modulation, we wondered
whether there was a counterpart present in CsESPs with
similar activity. In this study, we firstly identified a gene
encoding CsRNASET2, which also appeared to be a glyco-
protein of RNase T2 family. All RNase T2 enzymes have
two blocks of conserved amino acids (termed CAS I and
CAS II) [8,9]. These regions have typical catalytic residue
of one to three histidine residues [8,33]. Sequence analysis
showed that CsRNASET2 indeed harbored the two
Figure 4 Modulation of BMDCs maturation elicited by rCsRNASET2. (A) Days-7 BMDCs (2 × 106/ml) were stimulated with or without 0.5 μg/
ml rCsRNASET2, 0.5 μg/ml rCsFABP or 40 μg/ml ESPs in the presence of 1 μg/ml LPS for 24 h. The levels of CD11c, CD40, CD80 and CD86 on
BMDCs were detected by flow cytometry. Values stand for the percentage of treated cells staining positive for the indicated marker. Histograms
are representative of seven independent experiments. (B) Statistical results of the expression of surface markers on BMDCs. Data are expressed as
mean ± SD. Statistical significance was analyzed by the Mann–Whitney test (*p < 0.05, **p < 0.01, ns: not significant).
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dine residues (Figure 1). It suggested that CsRNASET2 was
the counterpart of Smomega-1. We expressed rCsRNA-
SET2 in P. pastoris with RNase activity. Deglycosylation
experiment displayed ~4 kDa size reduction of the
rCsRNASET2 (Figure 2A), which indicated the rCsRNA-
SET2 was indeed glycosylated. rCsRNASET2 could react
with C. sinensis-infected mouse sera and ESPs immunized
mouse sera, meanwhile, ESPs could be probed with mouse
anti-rCsRNASET2 sera at a single band (Figure 2B). These
results revealed that CsRNASET2 was indeed a component
of CsESPs, which are in accordance with the fact that the
RNase T2 family members are typically secreted [9,34]. The
difference of 8 kDa in molecular weight between rCsRNA-
SET2 and the native protein in ESP might be due to his/
myc-tag, a minor imprecision on SDS-PAGE assays andglycosylation (~4 kDa reduction). Meanwhile, we per-
formed western blot analysis, in which ESP reacted with
anti-rCsRNASET2 and anti-ESP mouse sera. Gradation
analysis revealed that CsRNASET2 took up about 2% of
ESP (Additional file 1: Figure S3).
Furthermore, ELISA assays revealed that the LPS-
induced up-regulation of IL-12p70 on BMDCs decreased
in a dose-dependent manner in the presence of various
concentrations of rCsRNASET2 or CsESP (Figure 3A). In
contrast, CsESPs (20–80 μg/ml) enhanced the expression
of IL-10 in a dose-dependent manner, and rCsRNASET2
could promote IL-10 synthesis only at a concentration of
0.5 μg/ml. Higher concentrations of rCsRNASET2 or ESP
failed to promote IL-10 production (Figure 3B). We then
performed BMDCs survival assay with Cell Counting kit-8
(CCK8) under different concentrations of rCsRNASET2
Figure 5 IgG subclass responses triggered by rCsRNASET2.
BALB/c mice (n = 6) were immunized s.c. with rCsRNASET2. After 4
(A) and 6 (B) weeks, sera levels of IgG1 and IgG2a specific for
rCsRNASET2 were evaluated by ELISA. IgG1 levels were significantly
higher than IgG2a at both 4th and 6th week. Error bars represent
mean levels ± SD. Statistical significance was analyzed by the Mann–
Whitney test (***p < 0.0005).
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rCsRNASET2 or ESP could inhibit cell viability (Additional
file 1: Figure S4). Therefore, we finally chose 0.5 μg/ml of
rCsRNASET2 and 40 μg/ml of ESP as moderate working
concentrations. CsFABP, a Th1-polarizing Ag, was utilized
to be a control protein. There was no significant difference
of cytokine production levels when rCsFABP was added.
Subsequently, we carried out flow cytometry analysis and
noted that levels of surface markers including CD11C,
CD40, CD80 and CD86 on rCsRNASET2- or CsESP-
treated BMDCs significantly decreased compared with LPS
controls, whereas rCsFABP displayed little effect on these
surface makers expression (Figure 4). These results demon-
strated that rCsRNASET2 could modulate the cytokine
production and maturation of DCs. Interleukin-12 (IL-12)
plays the key role in the generation of Th1 cells. IL-12p70
is a heterodimeric cytokine composed of two chains (p35
and p40), which is able to stimulate NK cells and T cells to
produce IFN-γ to resist against pathogens [35]. It has been
well established that IL-10 is a cytokine secreted by
CD4+ T cells belonging to the Th2 subset, which has
been determined to suppress the production of IFN-γ.
The induction of IL-10 may be an important strategy
by which parasites evade IFN-γ-dependent, cell-mediated
immune destruction [36]. Our experiments showed di-
minished expression of IL-12p70 and increased expression
of IL-10 in rCsRNASET2-cocultured DCs. Therefore, it is
conceivable that rCsRNASET2 co-cultured DCs may sup-
press Th1 polarization, which is eventually beneficial for
C. sinensis escaping from the host immunity.
IgG2a and IgGl immunoglobulin isotypes are generally
regarded as markers for Th1 and Th2 responses respec-
tively [29,37]. Our studies demonstrated that the up-
regulation of IgG1 was greater than that of IgG2a (Figure 5),confirming that Th2 responses might be dominant in
rCsRNASET2 immunized mice. These results were in
agreement with the data obtained from rCsRNASET2 co-
incubated BMDCs, as reduced expression of IL-12p70 and
increased production of IL-10 could inhibit Th1 po-
larization. However, it is difficult to determine the domin-
ance of Th1 or Th2 responses on the basis of IgG isotypes
alone, because the initiation of B cell isotype switching is
not only confined to the mutual effects of Th1 and Th2 cy-
tokines. Further studies are required to determine whether
CsRNASET2 is able to trigger Th2 or Treg responses
through DCs modulation, whether this function is associ-
ated with its RNase activity, and which pathways are in-
volved in the process.
Conclusion
Collectively, we cloned and identified CsRNASET2 as a
molecule present in C. sinensis ESPs. We confirmed that
rCsRNASET2 could regulate the host immune response
via modulating DCs maturation, as well as production of
IL-12p70 and IL-10. We also observed that administra-
tion of rCsRNASET2 to mice could alter the IgG1/IgG2a
ratio. It will be of significant interest to investigate
whether CsRNASET2 is able to initiate Th2 or Treg re-
sponses through modulating DCs, which will pave the
way towards unraveling the regulatory mechanisms of
the immune responses in C. sinensis infection and may
provide potential therapeutic tools.
Additional file
Additional file 1: Figure S1. Expression and purification of rCsRNASET2.
Figure S2. Determination of ribonuclease activity of rCsRNASET2. Figure
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assessment of rCsRNASET2.
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